Discovery and SAR Research for Antivirus Activity of Novel Butenolide on Influenza A Virus H1N1 In Vitro and In Vivo

Influenza viruses (IV) cause substantial morbidity and mortality through routine seasonal spread and epidemics. A novel series of butenolides were discovered to be able to inhibit influenza H1N1 activity in vitro, and the SAR for anti-influenza activity was investigated. By optimization of the hit compound, compound 37 was obtained with an EC50 of 6.7 μM against influenza A virus H1N1 as an inhibitor of NA and with low cytotoxicity on MDCK cells. Also, it can inhibit the expression of the influenza A virus gene in the lung of SPF KM mice to show antivirus activity in vivo. These results suggested that compound 37 could inhibit the influenza A virus H1N1 via targeting NA.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:4

Enthalten in:

ACS omega - 4(2019), 8 vom: 20. Aug., Seite 13265-13269

Sprache:

Englisch

Beteiligte Personen:

Wang, Zhenya [VerfasserIn]
Hu, Xiaoning [VerfasserIn]
Li, Yuanyuan [VerfasserIn]
Mou, Xiaodong [VerfasserIn]
Wang, Congcong [VerfasserIn]
Chen, Xinli [VerfasserIn]
Tan, Yayun [VerfasserIn]
Wu, Chunli [VerfasserIn]
Liu, Hongmin [VerfasserIn]
Xu, Haiwei [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Revised 01.10.2020

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1021/acsomega.9b01421

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM300699875